{
  "module": "PD_Structure_Checkpoints",
  "version": "1.0",
  "drugs": [
    {
      "drug": "levodopa",
      "order": 10,
      "checkpoints": [
        {
          "id": "fg",
          "title": "Select ALL functional groups present",
          "type": "multi_select",
          "attempts": 2,
          "choices": ["catechol", "amino_acid", "carboxylic_acid", "basic_amine", "propargylamine", "adamantane_core", "nitrocatechol_motif", "heterocycle"],
          "correct": ["catechol", "amino_acid", "carboxylic_acid"],
          "requires_tap_map": true,
          "tap_labels": ["catechol", "amino_acid", "carboxylic_acid"],
          "hint": "Levodopa is an amino acid with a catechol ring (two phenolic OH) and a carboxylic acid."
        },
        {
          "id": "pharm",
          "title": "Choose the best pharmacophore description",
          "type": "single_select",
          "attempts": 2,
          "choices": [
            "MAO-B inhibitor (propargylamine warhead)",
            "dopamine precursor (catechol amino acid scaffold)",
            "COMT inhibitor (nitrocatechol motif)",
            "dopamine agonist (basic heterocycle)"
          ],
          "correct": ["dopamine precursor (catechol amino acid scaffold)"],
          "hint": "Levodopa is a dopamine precursor and uses amino acid transport into the CNS."
        },
        {
          "id": "sar",
          "title": "Pick the most accurate SAR / concept statement",
          "type": "single_select",
          "attempts": 2,
          "choices": [
            "Catechol decreases metabolism by COMT",
            "Catechol increases COMT metabolism (shorter half-life without inhibitors)",
            "Propargylamine drives COMT inhibition",
            "Adamantane makes it highly polar and non-CNS"
          ],
          "correct": ["Catechol increases COMT metabolism (shorter half-life without inhibitors)"],
          "hint": "Catechols are classic COMT substrates; COMT inhibitors prolong levodopa effect."
        }
      ]
    },
    {
      "drug": "carbidopa",
      "order": 11,
      "checkpoints": [
        {
          "id": "pharm",
          "title": "Carbidopa is best described as:",
          "type": "single_select",
          "attempts": 2,
          "choices": [
            "central COMT inhibitor",
            "peripheral AADC inhibitor (does not cross BBB well)",
            "dopamine agonist",
            "NMDA antagonist"
          ],
          "correct": ["peripheral AADC inhibitor (does not cross BBB well)"],
          "hint": "Carbidopa inhibits peripheral dopa decarboxylase to increase levodopa reaching the brain."
        },
        {
          "id": "sar",
          "title": "Which property best explains its peripheral selectivity?",
          "type": "single_select",
          "attempts": 2,
          "choices": ["high lipophilicity", "high polarity / poor BBB penetration", "propargylamine motif", "adamantane cage"],
          "correct": ["high polarity / poor BBB penetration"],
          "hint": "Peripheral selectivity is taught as limited BBB penetration (more polar)."
        }
      ]
    },
    {
      "drug": "rasagiline",
      "order": 20,
      "checkpoints": [
        {
          "id": "fg",
          "title": "Select the key MAO-B inhibitor motif",
          "type": "single_select",
          "attempts": 2,
          "choices": ["propargylamine", "catechol", "nitrocatechol_motif", "carboxylic_acid"],
          "correct": ["propargylamine"],
          "requires_tap_map": true,
          "tap_labels": ["propargylamine"],
          "hint": "MAO-B inhibitors classically contain a propargylamine motif."
        },
        {
          "id": "pharm",
          "title": "Rasagiline is primarily a(n):",
          "type": "single_select",
          "attempts": 2,
          "choices": ["COMT inhibitor", "MAO-B inhibitor", "dopamine agonist", "dopamine precursor"],
          "correct": ["MAO-B inhibitor"],
          "hint": "Rasagiline inhibits MAO-B → decreases dopamine breakdown."
        }
      ]
    },
    {
      "drug": "selegiline",
      "order": 21,
      "checkpoints": [
        {
          "id": "fg",
          "title": "Select the key MAO-B inhibitor motif",
          "type": "single_select",
          "attempts": 2,
          "choices": ["propargylamine", "adamantane_core", "nitrocatechol_motif", "carboxylic_acid"],
          "correct": ["propargylamine"],
          "requires_tap_map": true,
          "tap_labels": ["propargylamine"],
          "hint": "Selegiline’s signature is the propargylamine warhead (classic MAO inhibitor feature)."
        },
        {
          "id": "sar",
          "title": "Key counseling concept (class-level) is:",
          "type": "single_select",
          "attempts": 2,
          "choices": [
            "risk of serotonin toxicity with serotonergic drugs (concept)",
            "severe chelation with dairy products",
            "always causes hepatotoxicity",
            "requires transdermal delivery"
          ],
          "correct": ["risk of serotonin toxicity with serotonergic drugs (concept)"],
          "hint": "Reinforce serotonergic interaction precautions as a class concept."
        }
      ]
    },
    {
      "drug": "entacapone",
      "order": 30,
      "checkpoints": [
        {
          "id": "fg",
          "title": "Select the motif most associated with COMT inhibition (teaching motif)",
          "type": "single_select",
          "attempts": 2,
          "choices": ["nitrocatechol_motif", "propargylamine", "adamantane_core", "amino_acid"],
          "correct": ["nitrocatechol_motif"],
          "requires_tap_map": true,
          "tap_labels": ["nitrocatechol_motif"],
          "hint": "COMT inhibitor scaffolds are commonly taught with a nitrocatechol-like motif."
        },
        {
          "id": "pharm",
          "title": "Entacapone is primarily a(n):",
          "type": "single_select",
          "attempts": 2,
          "choices": ["MAO-B inhibitor", "COMT inhibitor (peripheral)", "dopamine agonist", "NMDA antagonist"],
          "correct": ["COMT inhibitor (peripheral)"],
          "hint": "Entacapone inhibits COMT mainly peripherally to prolong levodopa effect."
        }
      ]
    },
    {
      "drug": "tolcapone",
      "order": 31,
      "checkpoints": [
        {
          "id": "pharm",
          "title": "Tolcapone differs from entacapone by:",
          "type": "single_select",
          "attempts": 2,
          "choices": [
            "having central + peripheral COMT inhibition (teaching distinction)",
            "being a dopamine agonist",
            "being a dopamine precursor",
            "being an NMDA antagonist"
          ],
          "correct": ["having central + peripheral COMT inhibition (teaching distinction)"],
          "hint": "Tolcapone is taught as more central-acting than entacapone."
        },
        {
          "id": "sar",
          "title": "Major safety flag to reinforce is:",
          "type": "single_select",
          "attempts": 2,
          "choices": ["hepatotoxicity risk", "serotonin toxicity risk", "chelation with metals", "patch-only delivery"],
          "correct": ["hepatotoxicity risk"],
          "hint": "Tolcapone has a well-known liver safety warning/monitoring requirement."
        }
      ]
    },
    {
      "drug": "pramipexole",
      "order": 40,
      "checkpoints": [
        {
          "id": "fg",
          "title": "Select the most important binding feature (teaching motif)",
          "type": "single_select",
          "attempts": 2,
          "choices": ["basic_amine", "nitrocatechol_motif", "propargylamine", "carboxylic_acid"],
          "correct": ["basic_amine"],
          "requires_tap_map": true,
          "tap_labels": ["basic_amine"],
          "hint": "Many dopamine agonists have an ionizable basic center important for receptor interaction."
        },
        {
          "id": "pharm",
          "title": "Pramipexole is primarily a(n):",
          "type": "single_select",
          "attempts": 2,
          "choices": ["dopamine agonist (D2/D3)", "dopamine precursor", "COMT inhibitor", "MAO-B inhibitor"],
          "correct": ["dopamine agonist (D2/D3)"],
          "hint": "Pramipexole is a dopamine agonist (commonly taught D2/D3)."
        }
      ]
    },
    {
      "drug": "ropinirole",
      "order": 41,
      "checkpoints": [
        {
          "id": "fg",
          "title": "Select the most important binding feature (teaching motif)",
          "type": "single_select",
          "attempts": 2,
          "choices": ["basic_amine", "catechol", "nitrocatechol_motif", "carboxylic_acid"],
          "correct": ["basic_amine"],
          "requires_tap_map": true,
          "tap_labels": ["basic_amine"],
          "hint": "Dopamine agonists often include an ionizable basic center."
        },
        {
          "id": "pharm",
          "title": "Ropinirole is primarily a(n):",
          "type": "single_select",
          "attempts": 2,
          "choices": ["dopamine agonist (D2/D3)", "dopamine precursor", "COMT inhibitor", "NMDA antagonist"],
          "correct": ["dopamine agonist (D2/D3)"],
          "hint": "Ropinirole is a dopamine agonist used for PD motor symptoms."
        }
      ]
    },
    {
      "drug": "rotigotine",
      "order": 42,
      "checkpoints": [
        {
          "id": "pharm",
          "title": "Rotigotine is best recognized as:",
          "type": "single_select",
          "attempts": 2,
          "choices": ["dopamine agonist delivered transdermally (patch)", "dopamine precursor", "MAO-B inhibitor", "COMT inhibitor"],
          "correct": ["dopamine agonist delivered transdermally (patch)"],
          "hint": "Rotigotine is commonly taught as the transdermal dopamine agonist."
        },
        {
          "id": "sar",
          "title": "Which property supports transdermal delivery (concept)?",
          "type": "single_select",
          "attempts": 2,
          "choices": ["higher lipophilicity", "high polarity", "zwitterion formation", "multiple charged centers"],
          "correct": ["higher lipophilicity"],
          "hint": "Transdermal delivery generally favors lipophilicity (within limits)."
        }
      ]
    },
    {
      "drug": "amantadine",
      "order": 50,
      "checkpoints": [
        {
          "id": "fg",
          "title": "Select the core scaffold",
          "type": "single_select",
          "attempts": 2,
          "choices": ["adamantane_core", "catechol", "nitrocatechol_motif", "propargylamine"],
          "correct": ["adamantane_core"],
          "requires_tap_map": true,
          "tap_labels": ["adamantane_core"],
          "hint": "Amantadine is an adamantane (cage) amine — rigid and lipophilic."
        },
        {
          "id": "pharm",
          "title": "Amantadine is best associated with which concept (teaching)?",
          "type": "single_select",
          "attempts": 2,
          "choices": ["NMDA antagonism / anti-dyskinesia concept", "COMT inhibition", "MAO-B inhibition", "AADC inhibition"],
          "correct": ["NMDA antagonism / anti-dyskinesia concept"],
          "hint": "Amantadine is taught as NMDA-related and used for dyskinesia management."
        }
      ]
    }
  ]
}
